Estrella Immunopharma, Inc. (ESLA) Dividend History

Estrella Immunopharma, Inc. (ESLA) is a biotechnology company focused on developing innovative therapies aimed at immune modulation and autoimmune diseases. The company leverages advanced immunological research to create treatments intended to improve patient outcomes in various immune-related conditions.

5858 Horton Street, Suite 370, Emeryville, CA, 94608
Phone: (510) 318-9098
Website: https://www.estrellabio.com

Dividend History

Estrella Immunopharma, Inc. currently does not pay dividends

Company News

  • Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers RiskOn International, Inc. (NASDAQ: ROI) shares rose 51.3% to $0.2250 in pre-market trading. Meta Materials Inc. (NASDAQ: MMAT) shares jumped 33.2% to $0.0966 in pre-market trading after surging over 20% on Tuesday. LQR House Inc. (NASDAQ: LQR) gained 25.2% to $2.53 in pre-market trading after dipping 45% on Tuesday. LQR House announced an increase of its share buyback program to $5 million. Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares climbed 19.3% to $0.1514 in pre-market trading after falling more than 9% on Tuesday. Zapp Electric Vehicles Group Limited (NASDAQ: ZAPP) shares gained 15.7% to $0.2950 in pre-market trading after dipping 13% on Tuesday. Solid Power, Inc. (NASDAQ: SLDP) gained 15.1% to $1.37 in pre-market trading. Solid Power deepened its partnership with SK On with three ...

    Benzinga
    Featured Companies: BANL DATS ELAB NTRA PHUN RVSN SLDP SLRX VERB
Page data last updated 09/08/2025 14:41:53 UTC